Ravindra Yeole

Employment

• Wockhardt Research Centre SCIENTIST
  1997 - Present

Education

• Wockhardt Research Centre M.PHARM. PhD

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Synthesis and characterization of four diastereomers of β-lactamase inhibitor drug intermediate
  Synthetic Communications 2024 DOI: 10.1080/00397911.2023.2290625
  +Save
• Synthesis, structural characterization of optical isomers and potential impurities in Alalevonadifloxacin mesylate
  Synthetic Communications 2023 DOI: 10.1080/00397911.2022.2163403
  +Save
• WCK 4873 (INN: Nafithromycin): Structure-Activity Relationship (SAR) Identifying a Novel Lactone Ketolide with Activity Against Pneumococci (SPN) and Streptococcus Pyogenes (SPY)
  2022 DOI: 10.2139/ssrn.4215669
  +Save
• Reverse‐phase chiral high‐performance liquid chromatography for separation of a diastereomer in alalevonadifloxacin: A novel antibacterial agent
  Biomedical Chromatography 2021 DOI: 10.1002/bmc.5079
  +Save
• Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic
  Xenobiotica 2021 DOI: 10.1080/00498254.2020.1839983
  +Save
• Assessment of in vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes
  Xenobiotica 2020 DOI: 10.1080/00498254.2020.1756007
  +Save
• <p>Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence</p>
  Drug Design, Development and Therapy 2019 DOI: 10.2147/DDDT.S229882
  +Save